ANGIOTECH ANNOUNCES POSITIVE ADHIBIT DATA TO PREVENT SURGICAL ADHESIONS
Angiotech Pharmaceuticals recently announced positive
results from a European pivotal clinical study conducted to evaluate the safety
and efficacy of Adhibit Adhesion Prevention Gel for the reduction of surgery
induced scars (adhesions) that can occur after surgery to remove fibroids from
the uterus (myomectomy surgery).